As of November 2024, CytoDyn has a market cap of $136.19M. This makes CytoDyn the world's 18983th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $142.21M | -15.00% |
2023 | $167.31M | -13.04% |
2022 | $192.40M | -76.77% |
2021 | $828.16M | -81.63% |
2020 | $4.51B | 439.00% |
2019 | $836.53M | 112.77% |
2018 | $393.17M | -14.55% |
2017 | $460.09M | -17.91% |
2016 | $560.47M | -12.99% |
2015 | $644.13M | -33.04% |
2014 | $962.01M | 9.52% |
2013 | $878.35M | -22.79% |
2012 | $1.14B | -54.52% |
2011 | $2.50B | 32.89% |
2010 | $1.88B | 31.58% |
2009 | $1.43B | 307.14% |
2008 | $351.34M | 44.83% |
2007 | $242.59M | -58.57% |
2006 | $585.57M | - |